Works by Gordon, Michael S.


Results: 104
    1
    2
    3
    4
    5
    6

    Avelumab Plus Axitinib as First-Line Therapy for Advanced Renal Cell Carcinoma: Long-Term Results from the JAVELIN Renal 100 Phase Ib Trial.

    Published in:
    Oncologist, 2023, v. 28, n. 4, p. 333, doi. 10.1093/oncolo/oyac243
    By:
    • Larkin, James;
    • Oya, Mototsugu;
    • Martignoni, Marcella;
    • Thistlethwaite, Fiona;
    • Nathan, Paul;
    • Ornstein, Moshe C;
    • Powles, Thomas;
    • Beckermann, Kathryn E;
    • Balar, Arjun V;
    • McDermott, David;
    • Gupta, Sumati;
    • Philips, George K;
    • Gordon, Michael S;
    • Uemura, Hirotsugu;
    • Tomita, Yoshihiko;
    • Wang, Jing;
    • Michelon, Elisabete;
    • Pietro, Alessandra di;
    • Choueiri, Toni K
    Publication type:
    Article
    7
    8
    9
    10
    11
    12

    Phase 1 study of mTORC1/2 inhibitor sapanisertib (TAK-228) in advanced solid tumours, with an expansion phase in renal, endometrial or bladder cancer.

    Published in:
    2020
    By:
    • Voss, Martin H.;
    • Gordon, Michael S.;
    • Mita, Monica;
    • Rini, Brian;
    • Makker, Vicky;
    • Macarulla, Teresa;
    • Smith, David C.;
    • Cervantes, Andrés;
    • Puzanov, Igor;
    • Pili, Roberto;
    • Wang, Ding;
    • Jalal, Shadia;
    • Pant, Shubham;
    • Patel, Manish R.;
    • Neuwirth, Rachel l.;
    • Enke, Aaron;
    • Shou, Yaping;
    • Sedarati, Farhad;
    • Faller, Douglas V.;
    • Burris III, Howard A.
    Publication type:
    journal article
    13
    14

    CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.

    Published in:
    Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.121.262485
    By:
    • Farwell, Michael D.;
    • Gamache, Raymond F.;
    • Babazada, Hasan;
    • Hellmann, Matthew D.;
    • Harding, James J.;
    • Korn, Ron;
    • Mascioni, Alessandro;
    • Le, William;
    • Wilson, Ian;
    • Gordon, Michael S.;
    • Wu, Anna M.;
    • Ulaner, Gary A.;
    • Wolchok, Jedd D.;
    • Postow, Michael A.;
    • Pandit-Taskar, Neeta
    Publication type:
    Article
    15

    CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.

    Published in:
    Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.121.262485
    By:
    • Farwell, Michael D.;
    • Gamache, Raymond F.;
    • Babazada, Hasan;
    • Hellmann, Matthew D.;
    • Harding, James J.;
    • Korn, Ron;
    • Mascioni, Alessandro;
    • Le, William;
    • Wilson, Ian;
    • Gordon, Michael S.;
    • Wu, Anna M.;
    • Ulaner, Gary A.;
    • Wolchok, Jedd D.;
    • Postow, Michael A.;
    • Pandit-Taskar, Neeta
    Publication type:
    Article
    16

    Title: CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.

    Published in:
    Journal of Nuclear Medicine, 2022, v. 63, n. 8, p. 1, doi. 10.2967/jnumed.121.262485
    By:
    • Farwell, Michael D.;
    • Gamache, Raymond F.;
    • Babazada, Hasan;
    • Hellmann, Matthew D.;
    • Harding, James J.;
    • Korn, Ron;
    • Mascioni, Alessandro;
    • Le, William;
    • Wilson, Ian;
    • Gordon, Michael S.;
    • Wu, Anna M.;
    • Ulaner, Gary A.;
    • Wolchok, Jedd D.;
    • Postow, Michael A.;
    • Pandit-Taskar, Neeta
    Publication type:
    Article
    17

    Title: CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.

    Published in:
    Journal of Nuclear Medicine, 2022, v. 63, n. 7, p. 1, doi. 10.2967/jnumed.121.262485
    By:
    • Farwell, Michael D.;
    • Gamache, Raymond F.;
    • Babazada, Hasan;
    • Hellmann, Matthew D.;
    • Harding, James J.;
    • Korn, Ron;
    • Mascioni, Alessandro;
    • Le, William;
    • Wilson, Ian;
    • Gordon, Michael S.;
    • Wu, Anna M.;
    • Ulaner, Gary A.;
    • Wolchok, Jedd D.;
    • Postow, Michael A.;
    • Pandit-Taskar, Neeta
    Publication type:
    Article
    18

    CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.

    Published in:
    Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.121.262485
    By:
    • Farwell, Michael D.;
    • Gamache, Raymond F.;
    • Babazada, Hasan;
    • Hellmann, Matthew D.;
    • Harding, James J.;
    • Korn, Ron;
    • Mascioni, Alessandro;
    • Le, William;
    • Wilson, Ian;
    • Gordon, Michael S.;
    • Wu, Anna M.;
    • Ulaner, Gary A.;
    • Wolchok, Jedd D.;
    • Postow, Michael A.;
    • Pandit-Taskar, Neeta
    Publication type:
    Article
    19

    CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.

    Published in:
    Journal of Nuclear Medicine, 2022, v. 63, n. 5, p. 1, doi. 10.2967/jnumed.121.262485
    By:
    • Farwell, Michael D.;
    • Gamache, Raymond F.;
    • Babazada, Hasan;
    • Hellmann, Matthew D.;
    • Harding, James J.;
    • Korn, Ron;
    • Mascioni, Alessandro;
    • Le, William;
    • Wilson, Ian;
    • Gordon, Michael S.;
    • Wu, Anna M.;
    • Ulaner, Gary A.;
    • Wolchok, Jedd D.;
    • Postow, Michael A.;
    • Pandit-Taskar, Neeta
    Publication type:
    Article
    20

    CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.

    Published in:
    Journal of Nuclear Medicine, 2022, v. 63, n. 3, p. 1, doi. 10.2967/jnumed.121.262485
    By:
    • Farwell, Michael D.;
    • Gamache, Raymond F.;
    • Babazada, Hasan;
    • Hellmann, Matthew D.;
    • Harding, James J.;
    • Korn, Ron;
    • Mascioni, Alessandro;
    • Le, William;
    • Wilson, Ian;
    • Gordon, Michael S.;
    • Wu, Anna M.;
    • Ulaner, Gary A.;
    • Wolchok, Jedd D.;
    • Postow, Michael A.;
    • Pandit-Taskar, Neeta
    Publication type:
    Article
    21

    CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.

    Published in:
    Journal of Nuclear Medicine, 2022, v. 63, n. 2, p. 1, doi. 10.2967/jnumed.121.262485
    By:
    • Farwell, Michael D.;
    • Gamache, Raymond F.;
    • Babazada, Hasan;
    • Hellmann, Matthew D.;
    • Harding, James J.;
    • Korn, Ron;
    • Mascioni, Alessandro;
    • Le, William;
    • Wilson, Ian;
    • Gordon, Michael S.;
    • Wu, Anna M.;
    • Ulaner, Gary A.;
    • Wolchok, Jedd D.;
    • Postow, Michael A.;
    • Pandit-Taskar, Neeta
    Publication type:
    Article
    22

    CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.

    Published in:
    Journal of Nuclear Medicine, 2022, v. 63, n. 1, p. 1, doi. 10.2967/jnumed.121.262485
    By:
    • Farwell, Michael D.;
    • Gamache, Raymond F.;
    • Babazada, Hasan;
    • Hellmann, Matthew D.;
    • Harding, James J.;
    • Korn, Ron;
    • Mascioni, Alessandro;
    • Le, William;
    • Wilson, Ian;
    • Gordon, Michael S.;
    • Wu, Anna M.;
    • Ulaner, Gary A.;
    • Wolchok, Jedd D.;
    • Postow, Michael A.;
    • Pandit-Taskar, Neeta
    Publication type:
    Article
    23

    Title: CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.

    Published in:
    Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.262485
    By:
    • Farwell, Michael D.;
    • Gamache, Raymond F.;
    • Babazada, Hasan;
    • Hellmann, Matthew D.;
    • Harding, James J.;
    • Korn, Ron;
    • Mascioni, Alessandro;
    • Le, William;
    • Wilson, Ian;
    • Gordon, Michael S.;
    • Wu, Anna M.;
    • Ulaner, Gary A.;
    • Wolchok, Jedd D.;
    • Postow, Michael A.;
    • Pandit-Taskar, Neeta
    Publication type:
    Article
    24

    CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.

    Published in:
    Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.262485
    By:
    • Farwell, Michael D.;
    • Gamache, Raymond F.;
    • Babazada, Hasan;
    • Hellmann, Matthew D.;
    • Harding, James J.;
    • Korn, Ron;
    • Mascioni, Alessandro;
    • Le, William;
    • Wilson, Ian;
    • Gordon, Michael S.;
    • Wu, Anna M.;
    • Ulaner, Gary A.;
    • Wolchok, Jedd D.;
    • Postow, Michael A.;
    • Pandit-Taskar, Neeta
    Publication type:
    Article
    25

    CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.

    Published in:
    Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.121.262485
    By:
    • Farwell, Michael D.;
    • Gamache, Raymond F.;
    • Babazada, Hasan;
    • Hellmann, Matthew D.;
    • Harding, James J.;
    • Korn, Ron;
    • Mascioni, Alessandro;
    • Le, William;
    • Wilson, Ian;
    • Gordon, Michael S.;
    • Wu, Anna M.;
    • Ulaner, Gary A.;
    • Wolchok, Jedd D.;
    • Postow, Michael A.;
    • Pandit-Taskar, Neeta
    Publication type:
    Article
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37

    Simulation and new learning technologies.

    Published in:
    Medical Teacher, 2001, v. 23, n. 1, p. 16, doi. 10.1080/01421590020007324
    By:
    • Issenberg, S. Barry;
    • Gordon, Michael S.;
    • Gordon, David Lee;
    • Safford, Robert E.;
    • Hart, Ian R.
    Publication type:
    Article
    38
    39
    40
    41
    42

    Evaluation of the effect of dabrafenib and metabolites on QTc interval in patients with <italic>BRAF</italic> V600–mutant tumours.

    Published in:
    British Journal of Clinical Pharmacology, 2018, v. 84, n. 4, p. 764, doi. 10.1111/bcp.13488
    By:
    • Nebot, Noelia;
    • Arkenau, Hendrik‐Tobias;
    • Infante, Jeffrey R.;
    • Chandler, Jason C.;
    • Weickhardt, Andrew;
    • Lickliter, Jason D.;
    • Sarantopoulos, John;
    • Gordon, Michael S.;
    • Mak, Gabriel;
    • St‐Pierre, Annie;
    • Tang, Lihua;
    • Mookerjee, Bijoyesh;
    • Carson, Stanley W.;
    • Hayes, Siobhan;
    • Grossmann, Kenneth F.
    Publication type:
    Article
    43
    44
    45
    46
    47
    48
    49

    Sodium balance modulates thirst in normal man.

    Published in:
    Endocrine Research, 1997, v. 23, n. 4, p. 377, doi. 10.1080/07435809709031864
    By:
    • Gordon, Michael S.;
    • Majzoub, Joseph A.;
    • Williams, Gordon H.;
    • Gordon, Murray B.
    Publication type:
    Article
    50

    Alpha-v Integrins as Therapeutic Targets in Oncology.

    Published in:
    Cancer Investigation, 2007, v. 25, n. 7, p. 632, doi. 10.1080/07357900701522638
    By:
    • Nemeth, Jeffrey A.;
    • Nakada, Marian T.;
    • Trikha, M.;
    • Lang, Zhihui;
    • Gordon, Michael S.;
    • Jayson, Gordon C.;
    • Corringham, Robert;
    • Prabhakar, Uma;
    • Davis, Hugh M.;
    • Beckman, Robert A.
    Publication type:
    Article